Synergistic Drug Combination of Nintedanib and Vardenafil Inhibits Fibrosis in AKR-2B Fibroblasts

M. Bourne (Rochester, United States of America), T. Kottom (Rochester, United States of America), A. Limper (Rochester, United States of America)

Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Session: Progress in basic and translational research on idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 5360
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bourne (Rochester, United States of America), T. Kottom (Rochester, United States of America), A. Limper (Rochester, United States of America). Synergistic Drug Combination of Nintedanib and Vardenafil Inhibits Fibrosis in AKR-2B Fibroblasts. 5360

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PP212 – The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
Source: ERS Lung Science Conference 2021
Year: 2021

Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

LSC - 2021 - The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Inhibition of LncRNA MALAT1 Protects H9c2 Cells against Intermittent Hypoxia-Induced Injury by Targeting MiRNA-193a-3p
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020

TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018



Cigarette Smoke Extract Promotes Human Lung Myofibroblast Differentiation by the Induction of Endoplasmic Reticulum Stress
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019


Mast Cell Tryptase Enhances Wound-Healing via Protease-Activated Receptor-2 Dependent Migration in Human Bronchial Epithelial Cells
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019



A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Aerosolized TLR7 Imidazoquinoline Agonist Bronchodilates In Vivo
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018



Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018



Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020